Video

Ofatumumab vs Teriflunomide: Phase 3 ASCLEPIOS I/II Open-Label Extension Study

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Videos
Anna Pace, MD
Kristyn Pocock, MD
Dementia expert James Galvin, MD, MPH, a professor of neurology at the University of Miami Miller School of Medicine, and chief scientific officer at CogniVue
Rami Burstein, PhD
Michael Kaplitt, MD, PhD
© 2025 MJH Life Sciences

All rights reserved.